Aurinia Pharmaceuticals AUPH Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's compensation and benefits?
- Aurinia Pharmaceuticals (AUPH) reported compensation and benefits of $8.62M in Q1 2026.
- How has Aurinia Pharmaceuticals's compensation and benefits changed year-over-year?
- Aurinia Pharmaceuticals's compensation and benefits increased by 40.0% year-over-year, from $6.16M to $8.62M.
- What is the long-term trend for Aurinia Pharmaceuticals's compensation and benefits?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's compensation and benefits has grown at a 10.7% compound annual growth rate (CAGR), from $11.36M to $18.87M.